Kedaara Capital is a private equity fund focused on growth-oriented strategic and minority investments in India. The company follows an operationally-oriented strategy and is dedicated to making value-oriented, private equity investments in Indian businesses with significant potential for improved business and financial performance.

Kedaara Capital

Kedaara Capital is an operationally oriented private equity firm pursuing control and minority investment opportunities in India.

Kedaara combines the strengths of a well-networked, highly experienced local investment advisory and operating team, with the experience of our international partner, Clayton, Dubilier & Rice, a pioneering global private equity firm whose investment model blends financial skills with operating expertise. We partner with entrepreneurs, management teams, and family-owned businesses and provide deep strategic & operational expertise, consultative approach, and global connectivity to build enduring value and competitiveness in such businesses.

Investment Philosophy

Kedaara was founded on a simple premise: market leading businesses are built with a sound strategy, driven entrepreneurs, and commitment to operating excellence. Our investment approach blends skilled investment judgment with extensive operating experience. Many enterprises, CEOs and entrepreneurs have selected Kedaara as their partner because of our strong reputation for trustworthiness, collaborative working and operational leadership.

We work with potential investee companies, primarily on an exclusive basis, to tailor transactions that address specific strategic and shareholder issues that matter most to them. What makes these transactions special is the flexibility, collaboration and sense of partnership that ensure each party’s needs are met and concerns addressed. Kedaara pursues investments where strategy, talent management, operational execution, and related business-building skills can drive significant value creation. While we typically invest between $25-75 million in each investment, we can invest a significantly larger amount (>$200 million) in select situations.

Kedaara focuses on two transaction themes with a common underlying goal of investing in well-positioned market leaders that could benefit from Kedaara’s unique skills to realize their true potential.

Spandana Sphoorty Financial Limited

Vijaya Diagnostic Centre

Aavas Financiers

Avanse Financial Services

It’s been an exciting start to the year for the Kedaara Capital team. We have relocated to our new office in Worli, Mumbai. We look forward to creating new memories and achieving greater milestones together.

Expressing gratitude to our earlier office in Sunshine Towers – you have been amazing and will hold a special place in our hearts! 

Thank you for your continued support. Also a big thank you to Puran Kumar and Studio PKA for their help and collaboration on our new amazing workplace!
 
Please note that our new address is: Altimus, 23rd Floor, 2301, Opposite Mahindra Towers, Dr. GM Bhosale Marg, Worli, Mumbai 400018.

Kedaara Capital is excited to announce its investment in K12 Techno Services Pvt. Ltd., a leading Indian education & technology services provider, for a significant minority stake. Through this investment, Kedaara seeks to support K12 Techno’s vision of providing high-quality holistic education services in India by leveraging technology and learnings across its network. 

K12 Techno is a technology and education services business providing full stack education, content, and technology services to more than 900 educational institutions across the country through a combination of own brand and a curriculum and technology platform. The company’s brand, content and technology are used by over 300,000 students in the K-12 space in India. Kedaara will work closely with the company's professional management team led by its CEO,  Jai Decosta, to augment its tech-enabled offering oriented towards world-class holistic education services.

Anant Gupta, Aashwit Mahajan, Kshama Jain, Saurabh Pinjani, Vikas Kumar, Aditya Kulkarni, Rishiraj Khajanchi, Pratik Ajmera, Sunish Sharma, Nishant Sharma

https://lnkd.in/dZbQC_Dx

Kedaara Capital is excited to announce its USD 229mn investment in Perfios, India’s leading B2B SaaS Fintech company. This represents one of the single biggest investments in the SaaS space in India.

Perfios plays on the strong secular growth and increasing digitization levels in the financial services sector in India and globally. With its first investment in the SaaS space, Kedaara looks forward to using its operational expertise and deep connectivity in the financial services and technology spaces to help support the company in the next phase of its growth journey. 

Founded by V.R Govindarajan and Debasish Chakraborty, and led by Sabyasachi Goswami, Perfios has established itself as a true market leader, with rapidly expanding footprint and differentiated product offerings.

Nishant Sharma K R Kamath Neeraj Swaroop Kartikeya Kaji Kartikey Gupta Saurabh Pinjani Aditya Kulkarni mani mulki Rishiraj Khajanchi Pratik Ajmera

https://lnkd.in/d_gZct7i

Kedaara Capital is excited to announce its acquisition of majority stake in Oliva Skin and Hair Clinics, a market leading medico-aesthetic dermatology services player in India. With its third investment in the single specialty healthcare segment, Kedaara aims to support and fuel Oliva’s growth towards realizing its vision of becoming India’s most respected and leading medico-aesthetic dermatology chain. Founded by Dr. Prashant Soma in 2009, Oliva has established itself as one of the largest and fastest growing players in the Indian dermatology space with market leading presence across major cities.

Nishant Sharma Ashutosh Sardesai Kshama Jain Kartikey Gupta Rutuj Shah Rishiraj Khajanchi Pratik Ajmera

https://lnkd.in/d6qZnee4

Kedaara Capital is excited to back ASG Eye Hospital in its transformative partnership with Vasan Healthcare Private Ltd and is delighted to welcome the entire Vasan team to the ASG family to enhance our mission of improving the delivery of high-quality and affordable eye-care across India.

Vasan is a highly trusted and valued brand and ASG will partner and work closely with all stakeholders in the Vasan ecosystem to ensure a seamless transition and to deliver unparalleled patient care. This combination will help us realize the vision of becoming the leading eye-care franchise by establishing the largest Pan India network of over 150 eye-care hospitals across 21 states.

Dr. Arun Singhvi Dr. Shilpi Gang Nishant Sharma Saakshi Gera Nishant N. Vikas Kumar Amit Mittal mani mulki Rohit Vyas Shantanu Rastogi Varun Talukdar Aakash Sachdev Kapil Piparaiya

Kedaara Capital is excited to welcome Govindarajan Narayanan as Operating Partner – Pharma, who will further enhance our senior operating team and reinforce our core purpose of identifying high quality businesses and leaders and actively guiding and advising them in creating industry-leading, robust businesses that create value for all stakeholders.
 
Govind brings over 3 decades of experience across a plethora of domains in the pharmaceutical and chemical industry mainly Bulk Drugs, Finished Dosages, CRAMS, Biotechnology, and Vaccines. He was the former Managing Director of Aurobindo Pharma Limited. He has played a pivotal role in accelerating growth by identifying new lines of business, new products, and markets. His strategy and approach have resulted in better execution, diversification, and transparency. Before Aurobindo, he served as the Managing Director and CEO of Shasun Pharmaceuticals Limited where he was the driving force for developing new businesses.

Metric
Company Name	Kedaara Capital
Symbol
MSH ID	COM:KEDAARA
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Private Equity
Country	IN
Stage
Employee Count	60
Website	kedaara.com
LinkedIn	kedaara-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:KEDAARA

Kedaara Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue